Description
BSE demat auction settlement listing securities and quantities for various companies including Adani Enterprises, Bank of India, Reliance Industries, and others.
Summary
BSE has published Settlement No. 703 dated August 29, 2025, listing securities available for demat auction. The settlement includes 53 different scrips with their corresponding codes, company names, and auction quantities ranging from 1 share to 97,500 shares.
Key Points
- Settlement No. 703 dated August 29, 2025
- 53 securities listed for demat auction
- Quantities range from 1 share (multiple companies) to 97,500 shares (DR. REDDY’S LABORATORIES)
- Includes major companies like Reliance Industries (14,008 shares), NMDC Ltd (27,000 shares), Bank of India (10,400 shares)
- Settlement covers diverse sectors including banking, pharmaceuticals, technology, and infrastructure
Regulatory Changes
No regulatory changes specified in this settlement notice.
Compliance Requirements
- Market participants must note the auction quantities for each listed security
- Settlement procedures to be followed as per BSE guidelines for demat auctions
- Participants should refer to specific scrip codes and quantities for trading purposes
Important Dates
- Settlement Date: August 29, 2025
- Settlement Number: 703
Impact Assessment
This demat auction settlement impacts shareholders and trading members dealing with the listed securities. The auction quantities indicate pending settlements that need to be resolved through the auction mechanism. Notable impacts include large quantities for companies like DR. Reddy’s Labs (97,500 shares), NMDC (27,000 shares), and Reliance Industries (14,008 shares), which may affect trading liquidity and settlement processes for these securities.
Impact Justification
Regular demat auction settlement affecting multiple listed securities with specified quantities for trading settlement